Literature DB >> 15631204

[Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases].

Patricia Q Díaz1, Helia T Bello, Mariana Y Domínguez, Natalia F Trabal, Sergio M Mella, Raúl Z Zemelman, Gerardo R González.   

Abstract

BACKGROUND: Klebsiella pneumoniae is a pathogenic bacterium frequently isolated from nosocomial samples, specially the subspecie pneunonlae, with extensive antibiolic resistance profiles, including third generation cepbhalosporiis, aminoglycosides and quinolones. This is specially true for those strains producing extended spectrum beta lactamases (ESBL). AIM: To investigate the susceptibility to gentamicin, amikacin and ciprofloxacin and the presence of some aminogloycoside modifying enzyme (AMEs) among nosocomial strains of K pneumoniae subspecie pneumoniae producing ESBL.
MATERIAL AND METHODS: The antibiotic resistant patterns and the level of resistance (minimal inhibitory concentration, MIC) of 100 strains, isoklted from sel ,eal bospitals of dcifferent Chilean cities, were deterl,in,ed. Tbe presence of some aminoglycosides modifying enzyme (AMEs) was investigated by PCR.
RESULTS: Sixty five percent of strains were resistant to gentamicin, 47% were resistant to amikacin, and 29% were resistant to ciprofloxacin. The most frequent AMEs genes detected were the aac(6')-Ib gene (6'N-Acetyltransferase type Ib enzyme) in 69% of strains, conferring resistance to amikacin, kanamycin, tobramycin, and nieoniycin, and the gene aac(3)-IIa (3-Acetyltransferase type 3-IIa enzyme), in 36% of strains, conferring resistance to gentamlicin.
CONCLUSIONS: Among nosocomial strains of K pneumoniae subspecie pneumoniae isolaterd from Chilean hospitals, there is an association between the production of ESBL and the resistance to others antimicrobial agents, especially aminoglycosides. Nevertheless, 71% of isolates are susceptible to ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15631204     DOI: 10.4067/s0034-98872004001000003

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

1.  CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem.

Authors:  Claudia Mugnaioli; Francesco Luzzaro; Filomena De Luca; Gioconda Brigante; Mariagrazia Perilli; Gianfranco Amicosante; Stefania Stefani; Antonio Toniolo; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Multiclonal Expansion of Klebsiella pneumoniae Isolates Producing NDM-1 in Rio de Janeiro, Brazil.

Authors:  Caio Augusto Martins Aires; Polyana Silva Pereira; Carlos Felipe Machado de Araujo; Thiago Pavoni Gomes Chagas; Jane Cleide Ribeiro Oliveira; Sibelle Nogueira Buonora; Rodolpho Mattos Albano; Ana Paula D'Alincourt Carvalho-Assef; Marise Dutra Asensi
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELA.

Authors:  Bertinellys Teixeira; Hectorina Rodulfo; Numirin Carreño; Militza Guzmán; Elsa Salazar; Marcos De Donato
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-03-22       Impact factor: 1.846

4.  A Multicenter Study of Beta-Lactamase Resistant Escherichia coli and Klebsiella pneumoniae Reveals High Level Chromosome Mediated Extended Spectrum β Lactamase Resistance in Ogun State, Nigeria.

Authors:  Folasoge A Adeyankinnu; Babatunde O Motayo; Akinniyi Akinduti; John Akinbo; Joseph I Ogiogwa; Bukola W Aboderin; R A Agunlejika
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-03-24

Review 5.  Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?

Authors:  Fatema Alhashem; Nicolette Leonie Tiren-Verbeet; Emine Alp; Mehmet Doganay
Journal:  World J Clin Cases       Date:  2017-08-16       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.